Shanghai Bloom Technology, Inc. (603325.SS) Bundle
Hitting the halfway mark between recovery and runway, Shanghai Bloom Technology's recent figures demand a closer look: Q3 2025 revenue rose to CNY 214 million (up 9.25% YoY) while TTM revenue as of July 31, 2025 reached CNY 1.34 billion-a 43.79% expansion-and first nine-month revenue totaled CNY 954.35 million versus CNY 581.33 million a year earlier; profitability shows a sharp rebound with Q3 net profit attributable to shareholders of CNY 71 million and a Q3 net profit margin of 33.14% (up 10.54 percentage points YoY), diluted TTM EPS of CNY 5.62 and an operating cash flow of CNY 445 million for the first three quarters (OCF/net income ≈ 1.38), while the balance sheet reflects a conservative capital structure with total debt of CNY 20 million, total equity of CNY 2.6 billion and a debt-to-equity ratio of 0.8% alongside cash and short-term investments of CNY 1.8 billion; valuation sits at a P/E of 13.93 and P/S of 5.12 with market cap around CNY 6.87 billion and enterprise value near CNY 6.22 billion, even as risks - over 70% China exposure, ~30% higher operational costs vs. peers, limited Western brand recognition (~15%) and a beta near 1.0 - counterbalance growth levers like AI/IoT demand and large-scale project pipelines (Yulong, Baofeng) that could accelerate revenue recognition, so investors should read on for granular analysis of revenue drivers, cash conversion, leverage, liquidity and the valuation trade-offs facing Bloom.
SHANGHAI BLOOM TECHNOLOGY INC (603325.SS) - Revenue Analysis
SHANGHAI BLOOM TECHNOLOGY INC (603325.SS) shows mixed short-term recovery and strong trailing momentum after a slight annual decline in 2024. Key top-line metrics for investors to note:
- Q3 2025 revenue: CNY 214.00 million, up 9.25% year-over-year.
- First three quarters 2025 cumulative revenue: CNY 954.35 million versus CNY 581.33 million in the same period of 2024 (substantial year-over-year increase).
- Annual revenue 2024: CNY 1.16 billion, down 5.43% from 2023.
- Trailing twelve months (TTM) revenue as of July 31, 2025: CNY 1.34 billion - a 43.79% increase (TTM basis).
- Revenue per employee: CNY 2.88 million based on 466 employees.
- Market capitalization: CNY 6.87 billion; price-to-sales (P/S) ratio: 5.12.
| Metric | Value | Comparison / Note |
|---|---|---|
| Q3 2025 Revenue | CNY 214.00M | +9.25% YoY |
| YTD (first 3 quarters) 2025 | CNY 954.35M | vs CNY 581.33M in 1-3Q 2024 |
| Annual Revenue 2024 | CNY 1.16B | -5.43% vs 2023 |
| TTM Revenue (to 31 Jul 2025) | CNY 1.34B | +43.79% on TTM basis |
| Employees | 466 | Revenue per employee: CNY 2.88M |
| Market Capitalization | CNY 6.87B | P/S = 5.12 |
Investor considerations based on these figures:
- Momentum: TTM revenue growth of 43.79% signals recovery and scaling after 2024's slight revenue contraction.
- Efficiency: Revenue per employee of CNY 2.88M suggests relatively high productivity for headcount size (466 employees).
- Valuation: A P/S of 5.12 at CNY 6.87B market cap implies investor expectations for continued above-market growth; assess margin expansion potential to justify valuation.
- Quarterly trend: Q3 2025 growth (+9.25% YoY) supports sequential improvement but compare against seasonality and segment mix.
For context on corporate direction and long-term strategic priorities, see: Mission Statement, Vision, & Core Values (2026) of SHANGHAI BLOOM TECHNOLOGY INC.
SHANGHAI BLOOM TECHNOLOGY INC (603325.SS) - Profitability Metrics
SHANGHAI BLOOM TECHNOLOGY INC reported marked improvements in profitability and cash generation in 2025, driven by stronger margins, higher net profit, and efficient cash conversion.- Q3 2025 net profit attributable to shareholders: CNY 71.0 million (YoY +60.20%).
- Q3 2025 net profit margin: 33.14% (up 10.54 percentage points YoY).
- Comprehensive net profit margin for first three quarters of 2025: 29.14% (up 5.82 percentage points YoY).
- Trailing twelve months diluted EPS: CNY 5.62.
- Operating cash flow for first three quarters of 2025: CNY 445.0 million.
- Operating cash flow / Net income ratio: ~1.38, indicating operating cash significantly exceeds reported net income.
| Metric | Q3 2025 | Q3 2024 (for comparison) | First 3Q 2025 | YoY Change (where applicable) |
|---|---|---|---|---|
| Net profit attributable (CNY) | 71.0M | 44.3M | - | +60.20% |
| Net profit margin | 33.14% | 22.60% | - | +10.54 pp |
| Comprehensive net profit margin (first 3Q) | - | - | 29.14% | +5.82 pp |
| Operating cash flow (first 3Q, CNY) | - | - | 445.0M | Substantially > Net income |
| Operating cash flow / Net income | - | - | ~1.38 | - |
| Diluted EPS (TTM) | - | - | 5.62 CNY | - |
- High net profit margin (33.14% in Q3) signals pricing power and cost control during the quarter.
- Operating cash flow materially above net income (ratio ~1.38) points to strong cash conversion and lower accrual-based earnings risk.
- TTM diluted EPS of CNY 5.62 provides a clear per-share earnings baseline for valuation and dividend considerations.
SHANGHAI BLOOM TECHNOLOGY INC (603325.SS) - Debt vs. Equity Structure
SHANGHAI BLOOM TECHNOLOGY INC (603325.SS) displays a capital structure characterized by very low gearing, substantial equity backing and significant liquid assets relative to its debt load.
- Total debt (as of September 30, 2024): CNY 20 million
- Total equity (as of September 30, 2024): CNY 2.6 billion
- Debt-to-equity ratio: 0.8%
- Interest coverage ratio: -7.2x (reported)
- Total assets: CNY 5.6 billion
- Total liabilities: CNY 3.0 billion
- Cash and short-term investments: CNY 1.8 billion
- Enterprise value: CNY 6.22 billion
- Market capitalization: CNY 6.26 billion
| Metric | Amount (CNY) | Ratio / Note |
|---|---|---|
| Total Assets | 5,600,000,000 | - |
| Total Liabilities | 3,000,000,000 | - |
| Total Equity | 2,600,000,000 | - |
| Total Debt | 20,000,000 | Includes short- and long-term debt |
| Debt-to-Equity Ratio | 0.8% | Total Debt / Total Equity |
| Interest Coverage Ratio | -7.2x | Reported (negative value) |
| Cash & Short-term Investments | 1,800,000,000 | Liquid reserves on the balance sheet |
| Enterprise Value | 6,220,000,000 | Market cap + net debt |
| Market Capitalization | 6,260,000,000 | Market value of equity |
Key implications for investors:
- Very low leverage: a 0.8% debt-to-equity ratio indicates the company relies predominantly on equity financing.
- Strong liquidity buffer: CNY 1.8 billion in cash and short-term investments helps meet near-term obligations and reduces refinancing risk.
- Balance-sheet scale: with CNY 5.6 billion in assets and CNY 3.0 billion in liabilities, equity provides a sizable cushion.
- Enterprise value versus market cap: EV (CNY 6.22B) is closely aligned with market cap (CNY 6.26B), reflecting minimal net debt.
- Interest coverage anomaly: the reported -7.2x ratio is notable and should prompt review of operating income and interest expense items for context.
Further background on corporate history, ownership and how the company operates can be found here: SHANGHAI BLOOM TECHNOLOGY INC: History, Ownership, Mission, How It Works & Makes Money
SHANGHAI BLOOM TECHNOLOGY INC (603325.SS) - Liquidity and Solvency
Key liquidity and solvency metrics for SHANGHAI BLOOM TECHNOLOGY INC (603325.SS) provide a snapshot of short-term cash resources and long-term balance-sheet risk as of the first three quarters of 2024.
- Cash balance (30 Sep 2024): CNY 668 million
- Net cash flow from operating activities (1H-3Q 2024): CNY 445 million
- Operating cash flow to net income ratio: ~1.38 (strong cash conversion)
- Interest coverage ratio: -7.2x
- Debt-to-equity ratio: 0.8%
- Current ratio and quick ratio: not specified in available data
| Metric | Value | Interpretation |
|---|---|---|
| Cash balance (30‑Sep‑2024) | CNY 668 million | Adequate short‑term liquidity buffer |
| Net operating cash flow (Q1-Q3 2024) | CNY 445 million | Positive operating cash generation |
| Operating cash flow / Net income | 1.38x | Cash generation exceeds accounting profits (good conversion) |
| Interest coverage ratio | -7.2x | Reported negative value per source |
| Debt‑to‑Equity | 0.8% | Very low leverage; solvency structurally supported |
| Current & Quick Ratios | Not specified | Requires supplemental disclosure for short‑term liquidity detail |
Putting the figures together:
- The CNY 668M cash balance plus CNY 445M net operating cash inflow through Q3 2024 point to robust near‑term liquidity.
- A 1.38 operating cash flow / net income ratio indicates efficient conversion of earnings into cash.
- Debt levels are minimal (0.8% debt/equity), supporting long‑term solvency despite the reported -7.2x interest coverage ratio in available data.
Additional context and corporate direction can be found here: Mission Statement, Vision, & Core Values (2026) of SHANGHAI BLOOM TECHNOLOGY INC.
SHANGHAI BLOOM TECHNOLOGY INC (603325.SS) - Valuation Analysis
| Metric | Value (CNY) | Notes |
|---|---|---|
| Trailing Twelve Months EPS | 5.62 | Used to compute P/E |
| Price-to-Earnings (P/E) | 13.93 | Trailing twelve months basis |
| TTM Revenue | 1.34 billion | Used to compute P/S |
| Price-to-Sales (P/S) | 5.12 | TTM revenue basis |
| Total Equity (Book Value) | 2.6 billion | Used to compute P/B |
| Price-to-Book (P/B) | 2.30 | Book value per share basis |
| Market Capitalization (reported) | 6.87 billion | Primary market cap cited |
| Market Capitalization (alternative) | 6.26 billion | Alternative reported figure |
| Enterprise Value (EV) | 6.22 billion | EV reported |
- P/E 13.93: implies investors pay ~14x trailing earnings; indicates moderate earnings multiple versus growth expectations.
- P/S 5.12 with CNY 1.34B revenue: revenue multiple is elevated, reflecting either higher margins, growth anticipation, or limited top-line scale.
- P/B 2.30 on CNY 2.6B equity: equity is trading above book by ~130%, suggesting market values intangible assets, growth prospects, or ROE premiums.
- EV (6.22B) vs. Market Cap (6.26-6.87B): EV close to market cap indicates relatively low net debt or balanced cash/debt position.
- Relative stance: valuation metrics place SHANGHAI BLOOM TECHNOLOGY INC in a moderate valuation band - not deeply cheap on P/S or P/B, and P/E in the mid-teens.
- Key implications for investors: focus on revenue growth trajectory, margin sustainability, and return on equity to justify current multiples.
SHANGHAI BLOOM TECHNOLOGY INC (603325.SS) Risk Factors
Key risks that materially affect SHANGHAI BLOOM TECHNOLOGY INC's financial health and investor outlook are summarized below, with quantified indicators where available.
- Concentration risk: Over 70% of group revenues are generated within China, exposing the company to domestic economic cycles, policy shifts, and regional demand fluctuations.
- Cost structure pressure: Operational costs run roughly 30% above the industry average due to sustained investments in advanced powder-handling technologies and specialized talent, compressing operating margins.
- Limited international brand recognition: Western-market familiarity is approximately 15%, constraining export growth and pricing power outside Asia.
- Workforce communication gaps: Communication barriers affect about 25% of employees, which can reduce operational efficiency, delay project timelines, and increase indirect costs.
- Market volatility exposure: The stock exhibits a beta near 1.0, indicating returns largely move in line with the broader market and are susceptible to market-wide downturns.
- Industry cyclicality and competitive intensity: The powder handling equipment market is highly competitive and cyclical, closely tied to levels of industrial investment in China-demand can swing with capex cycles.
| Risk Factor | Quantified Metric / Estimate | Potential Financial Impact |
|---|---|---|
| Revenue concentration (China) | >70% of revenues | Top-line volatility from domestic slowdown; limited natural hedging from international sales |
| Operational cost premium | ~30% above industry average | Lower gross & operating margins; higher break-even threshold |
| Brand recognition (Western markets) | ~15% familiarity | Slower overseas revenue growth; higher marketing and sales investment required |
| Employee communication barriers | ~25% of workforce affected | Productivity losses, longer cycle times, potential quality/control incidents |
| Equity market sensitivity | Beta ≈ 1.0 | Share price mirrors market swings; limited defensive characteristic |
| Industry dynamics | Competitive & cyclical market (powder handling) | Revenue and margin variability tied to CAPEX cycles in China |
Risks interact: high domestic revenue concentration combined with a cyclical, competitive market and elevated operating costs can amplify earnings volatility. Strategic initiatives and capital allocation decisions should be evaluated against these quantified exposures. See the company's stated priorities here: Mission Statement, Vision, & Core Values (2026) of SHANGHAI BLOOM TECHNOLOGY INC.
SHANGHAI BLOOM TECHNOLOGY INC (603325.SS) - Growth Opportunities
SHANGHAI BLOOM TECHNOLOGY INC (603325.SS) sits at an intersection of several high-growth end markets-AI, IoT, and large-scale refining & chemical equipment-creating multiple avenues to expand revenue and margins as global demand accelerates.
- Geographic expansion: Targeting emerging markets such as India and Vietnam can diversify revenue concentration and capture faster-growing industrial capex cycles in Southeast Asia and South Asia.
- Product evolution: Continued development and enhancement of AI-enabled and IoT-integrated product lines is essential to capture the rising demand for smart industrial equipment and predictive-maintenance solutions.
- Large-project participation: Participation in integrated refining & chemical projects (domestic and overseas) should drive demand for Bloom's large-scale equipment and EPC-related revenue recognition as projects like Yulong and Baofeng progress through construction to commissioning.
| Growth Vector | Relevant Metric / Projection | Implication for SHANGHAI BLOOM |
|---|---|---|
| Global AI Market | $190 billion by 2025; CAGR ~36% | Opens channels for AI-driven control systems, analytics, and edge devices-higher ASPs and recurring software/service revenue. |
| IoT Market | $1.1 trillion by 2026; CAGR ~24% | Broadens demand for sensor-integrated equipment and IoT-enabled service contracts (condition monitoring, remote service). |
| Large-scale refining & chemical projects | Accelerated project pipelines in China & ME-multi-year EPC timelines | Steady large-ticket order flow and elevated revenue recognition when projects (e.g., Yulong, Baofeng) move into later stages. |
| Emerging Markets (India, Vietnam) | High industrial capex growth vs. mature markets (double-digit YoY infrastructure/chemical investment growth in select regions) | Opportunity to grow installed base, local partnerships, and after-sales service revenue. |
- Strategic go-to-market moves: Forming local JV/partnerships in India and Vietnam, tailoring financing solutions for large EPC buyers, and expanding service contracts can accelerate market penetration and improve lifetime revenue per customer.
- Technology roadmap priorities:
- Embed AI for process optimization and predictive maintenance to reduce customer OPEX and create subscription-like revenue.
- Integrate IoT platforms to enable remote diagnostics, spare-parts analytics, and SLA-backed service offerings.
Key project linkages and investor resources: Mission Statement, Vision, & Core Values (2026) of SHANGHAI BLOOM TECHNOLOGY INC.

Shanghai Bloom Technology, Inc. (603325.SS) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.